SynthesisBreast (Edinburgh, Scotland)2023

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.

Anna-Maria Lazaratos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.